Sodium acetate trihydrate, 99.5%

GMP
Synonyms: 三水合乙酸钠,99.5%
Sodium acetate trihydrate, 99.5% 是一种具有多种生物活性的短链脂肪酸盐,作为乙酰辅酶 A 的直接前体,可通过促进组蛋白乙酰化广泛影响基因表达,并能激活 p38 MAPK 通路诱导癌细胞凋亡 (apoptosis),激活 Wnt/β-catenin 信号通路刺激盲肠上皮细胞的增殖和迁移以改善肠道健康,同时通过上调睾酮依赖的 eNOS/NO/cGMP 信号通路并激活 Nrf2/HO-1 通路及其下游抗氧化酶,从而减轻铅积累和氧化损伤。
产品编号: MS-X00131 纯度: 99.99% CAS No.: 6131-90-4 分子式: C2H9NaO5 分子量: 136.08
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
25g
询价
3-5 天
50g
询价
3-5 天
100g
询价
3-5 天
500g
询价
3-5 天
> 100g
询价
询价

产品描述

Sodium acetate trihydrate, 99.5% 是一种具有多种生物活性的短链脂肪酸盐,作为乙酰辅酶 A 的直接前体,可通过促进组蛋白乙酰化广泛影响基因表达,并能激活 p38 MAPK 通路诱导癌细胞凋亡 (apoptosis),激活 Wnt/β-catenin 信号通路刺激盲肠上皮细胞的增殖和迁移以改善肠道健康,同时通过上调睾酮依赖的 eNOS/NO/cGMP 信号通路并激活 Nrf2/HO-1 通路及其下游抗氧化酶,从而减轻铅积累和氧化损伤。

生物实验数据

生物活性 Sodium acetate trihydrate, 99.5% is a short-chain fatty acid salt with multiple biological activities that serves as a direct precursor of acetyl-CoA, broadly influencing gene expression by promoting histone acetylation, inducing cancer cell apoptosis via activation of the p38 MAPK pathway, stimulating cecal epithelial cell proliferation and migration to improve intestinal health through activation of the Wnt/β-catenin signaling pathway, and alleviating lead accumulation and oxidative damage by upregulating the testosterone-dependent eNOS/NO/cGMP signaling pathway and activating the Nrf2/HO-1 pathway and its downstream antioxidant enzymes.
体外研究
(In Vitro)

Sodium acetate trihydrate (1-5%; 1 h) 对 MKN1-Luc 和 MKN45-Luc 胃癌细胞具有浓度和时间依赖性的抗肿瘤作用。
Sodium acetate trihydrate (3%; 1 h) 以血浆暴露时间依赖的方式诱导 MKN1-Luc 和 MKN45-Luc 胃癌细胞发生凋亡,其中 MKN45-Luc 细胞敏感性更高,而对人正常腹膜间皮细胞无影响。
Sodium acetate trihydrate (3%; 12 h) 可诱导 MKN45-Luc 胃癌细胞发生凋亡形态学改变,包括泡状突起形成,且该变化在处理后 1.5 h 开始出现。
Sodium acetate trihydrate (3%; 1 h) 可通过提高 MKN1-Luc 和 MKN45-Luc 胃癌细胞中磷酸化 MKK3/MKK6 与磷酸化 p38 MAPK 的水平激活 p38 MAPK 通路。
Sodium acetate trihydrate (1-5%; 1-10 min) 可使血浆中的 H2O2、NO2−、Na+、葡萄糖及乳酸浓度随暴露时间呈时间依赖性升高,而 K+水平无变化。
Sodium acetate (2 mM; 24-48 h) trihydrate 可通过激活 Wnt/β-catenin 通路促进兔原代盲肠上皮细胞的增殖与迁移,细胞增殖增强、划痕面积减小、增殖相关基因表达上调以及 β-catenin 磷酸化水平和核定位改变可佐证这一结论。
Sodium acetate (10 mM; 16-24 h) trihydrate 可增强钙离子载体 A23187 在 DMSO 分化的中性粒细胞样 HL-60 细胞中诱导的不依赖 NOX 的中性粒细胞胞外诱捕网形成 (NETosis),且该效应随孵育时间延长而增强。
Sodium acetate (10 mM; 24 h) trihydrate 可增强 A23187 诱导的经 DMSO 分化的中性粒细胞样 HL-60 细胞的胞外 DNA 释放,该效应依赖于细胞内 ACSS2 的活性。
Sodium acetate (1-10 mM; 1-24 h) trihydrate 以浓度和时间依赖的方式上调经 DMSO 分化的中性粒细胞样 HL-60 细胞的整体组蛋白乙酰化水平,在 10 mM 处理 24 h 后可观察到显著的乙酰化现象。
Sodium acetate (10 mM; 24 h) trihydrate 可显著提高 DMSO 分化的中性粒细胞样 HL-60 细胞中组蛋白 H3 的 H3K9 和 H3K14 位点乙酰化水平,降低 H3K18 位点的乙酰化水平,且对 H3K27 位点的乙酰化无显著影响。
Sodium acetate (10 mM; 24 h) trihydrate 可提高经 DMSO 分化的中性粒细胞样 HL-60 细胞中的组蛋白乙酰化水平,该水平在经 10 μM A23187 刺激 0.5 h 内即快速降低。
Sodium acetate (10 mM; 24 h) trihydrate 可增强 A23187 诱导的组蛋白 H3 瓜氨酸化,且不会改变经 DMSO 分化的中性粒细胞样 HL-60 细胞中 PAD4 的表达。

Apoptosis Analysis

Cell Line: human gastric cancer cell lines MKN1-Luc, MKN45-Luc; normal human peritoneal mesothelial cells
Concentration: 3% PASA
Incubation Time: 1 h (treatment); plasma exposure times 0, 1, 3, 5, 10 min
Result: Increased percentages of apoptotic plus dead MKN1-Luc and MKN45-Luc cells significantly at 3 min plasma exposure.
Induced ~70% apoptotic plus dead cells in MKN45-Luc cells at plasma exposure times ≥3 min, showing higher sensitivity to 3% PASA than MKN1-Luc cells.
Caused no significant change in the percentage of apoptotic and dead cells in normal peritoneal mesothelial cells at plasma exposure times ≥3 min.

Western Blot Analysis

Cell Line: human gastric cancer cell lines MKN1-Luc, MKN45-Luc
Concentration: 3% PASA
Incubation Time: 10 min (plasma exposure); 1 h (treatment)
Result: Increased phosphorylated MKK3/MKK6 protein expression levels significantly in both MKN1-Luc and MKN45-Luc cells compared with control.
Increased phosphorylated p38 MAPK protein expression levels significantly in both MKN1-Luc and MKN45-Luc cells compared with control.

Western Blot Analysis

Cell Line: DMSO-differentiated neutrophil-like HL-60 (nHL-60) cells
Concentration: 1 mM, 10 mM
Incubation Time: 24 h
Result: Did not alter the expression levels of ACSS2, MCT-1, or MCT-4 proteins compared to untreated controls.

Western Blot Analysis

Cell Line: DMSO-differentiated neutrophil-like HL-60 (nHL-60) cells
Concentration: 1 mM, 10 mM
Incubation Time: 1 h, 24 h
Result: Increased global histone acetylation in a concentration- and time-dependent manner: minimal acetylation was observed after 1 h, while marked acetylation was detected after 24 h, with a greater effect at 10 mM compared to 1 mM.

Western Blot Analysis

Cell Line: DMSO-differentiated neutrophil-like HL-60 (nHL-60) cells
Concentration: 10 mM
Incubation Time: 24 h
Result: Significantly increased acetylation at histone H3 residues H3K9 and H3K14.
Decreased acetylation at H3K18, and did not significantly alter acetylation at H3K27.

Western Blot Analysis

Cell Line: DMSO-differentiated neutrophil-like HL-60 (nHL-60) cells
Concentration: 10 mM (sodium acetate); 10 μM (A23187 stimulation)
Incubation Time: 24 h (sodium acetate); 0.5 h, 1 h, 2 h (A23187 stimulation)
Result: Increased histone acetylation in nHL-60 cells, but this acetylation was rapidly reduced after A23187 stimulation, with levels dropping significantly within 0.5 h of stimulation.

Western Blot Analysis

Cell Line: DMSO-differentiated neutrophil-like HL-60 (nHL-60) cells
Concentration: 10 mM (sodium acetate); 10 μM (A23187 stimulation)
Incubation Time: 24 h (sodium acetate); 3 h (A23187 stimulation for histone citrullination analysis)
Result: Significantly enhanced A23187-induced histone H3 citrullination, but did not alter the expression level of PAD4 (the enzyme responsible for histone citrullination).
体内研究
(In Vivo)

Sodium acetate (200 mg/kg;口服;每日一次;28 天) trihydrate 可通过上调睾酮依赖的 eNOS/NO/cGMP 信号通路并激活 Nrf2/HO-1 通路,减轻铅诱导的雄性 Wistar 大鼠性功能障碍。
Sodium acetate (2 g/kg;口服;自由摄取;10 周) trihydrate 可提升雄性新西兰白兔的生长性能与肠道健康。

Animal Model: Wistar (male, 10 weeks old, similar weights, lead acetate-induced sexual dysfunction)
Dosage: 200 mg/kg/day
Administration: p.o.; daily; 28 days
Result: Improved lead-induced reductions in absolute and relative penile weight.
Decreased penile lead concentration.
Shortened prolonged mount, intromission, and ejaculation latency.
Increased reduced mount, intromission, and ejaculation frequency.
Improved reduced motivation to mate and penile reflex.
Restored penile eNOS, NO, and cGMP concentrations.
Attenuated increased penile acetylcholinesterase activity.
Increased reduced plasma LH, FSH, testosterone, and dopamine concentrations.
Blunted lead-induced increases in penile MDA and GSSG concentrations and restored GSH concentrations and GSH/GSSG ratio.
Upregulated reduced penile GR, GPx, GST, SOD, and catalase activities.
Restored reduced penile Nrf2 and HO-1 concentrations.
Minimized penile vascular congestion compared to lead-only treated rats.
Animal Model: New Zealand White (male, 35 days old, 1.70 kg)
Dosage: 2 g/kg
Administration: oral; ad libitum; 10 weeks
Result: Improved growth performance and intestinal health in male New Zealand White rabbits, as evidenced by a 27.12% reduction in feed conversion ratio, decreased diarrhea score, enhanced cecal antioxidant capacity, and activation of the Wnt/β-catenin pathway to support cecal epithelial cell function
性状 固体
颜色 White to off-white

化学信息

分子量 136.08
分子式 C2H9NaO5
CAS No. 6131-90-4
别名 三水合乙酸钠,99.5%

储存&溶解度

储存方式

Store at room temperature, keep dry and cool

In solvent -80°C 1 year
-20°C 6 months
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

H2O 中的溶解度 : ≥ 200 mg/mL (1458.90 mM)

* "≥" means soluble, but saturation unknown.

可选溶剂浓度1 mg5 mg10 mg25 mg
H2O1 mM7.2945 mL36.4724 mL72.9448 mL182.3620 mL
5 mM1.4589 mL7.2945 mL14.5890 mL36.4724 mL
10 mM0.7294 mL3.6472 mL7.2945 mL18.2362 mL
15 mM0.4863 mL2.4315 mL4.8630 mL12.1575 mL
20 mM0.3647 mL1.8236 mL3.6472 mL9.1181 mL
25 mM0.2918 mL1.4589 mL2.9178 mL7.2945 mL
30 mM0.2431 mL1.2157 mL2.4315 mL6.0787 mL
40 mM0.1824 mL0.9118 mL1.8236 mL4.5590 mL
50 mM0.1459 mL0.7294 mL1.4589 mL3.6472 mL
60 mM0.1216 mL0.6079 mL1.2157 mL3.0394 mL
80 mM0.0912 mL0.4559 mL0.9118 mL2.2795 mL
100 mM0.0729 mL0.3647 mL0.7294 mL1.8236 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 1 year; -20°C, 6 months。-80°C储存时,请在1年内使用, -20°C储存时,请在6个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础